Tumour-proliferative fraction and growth factor expression as markers of tumour response to radiotherapy in cancer of the uterine cervix

[1]  M. Nair,et al.  Tumor proliferative fraction in infiltrating duct carcinoma. , 1997, General & diagnostic pathology.

[2]  M. Nair,et al.  Proliferating cell nuclear antigen expression and the progression of cervical intraepithelial neoplasia. , 1996, Oncology reports.

[3]  M. Nair,et al.  Expression of epidermal and transforming growth factors in pancreatic cancer. , 1996, Oncology reports.

[4]  K. Flanders,et al.  Altered expression of transforming growth factor‐β1 in cervical neoplasia as an early biomarker in carcinogenesis of the uterine cervix , 1996, Cancer.

[5]  C. West,et al.  Invited review: intrinsic radiosensitivity as a predictor of patient response to radiotherapy. , 1995, The British journal of radiology.

[6]  T. Nakano,et al.  Differential values of ki‐67 index and mitotic index of proliferating cell population. An assessment of cell cycle and prognosis in radiation therapy for cervical cancer , 1993, Cancer.

[7]  P. Jayaprakash,et al.  Argyrophilic nucleolar organizer regions (AgNORs) in inflammatory pre-malignant and malignant lesions of the uterine cervix. , 1993, Cancer letters.

[8]  S. Davidson,et al.  Lack of association between in vitro clonogenic growth of human cervical carcinoma and tumour stage, differentiation, patient age, host cell infiltration or patient survival , 1992, International journal of cancer.

[9]  J. Schulte‐Mönting,et al.  Ki‐67 immunostaining in human breast tumors and its relationship to prognosis , 1991, Cancer.

[10]  E. Tahara,et al.  EGF and TGF‐α, the ligands of hyperproduced EGFR in human esophageal carcinoma cells, act as autocrine growth factors , 1990 .

[11]  D. Boldy,et al.  How should we count AgNORS? Proposals for a standardized approach , 1989, The Journal of pathology.

[12]  K. Aozasa,et al.  Prognostic significance of Ki‐67 reactivity in soft tissue sarcomas , 1989, Cancer.

[13]  H Stein,et al.  Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. , 1984, Journal of immunology.

[14]  W. Sewchand,et al.  The Influence of Patientsʼ Age and Tumor Grade on the Prognosis of Carcinoma of the Cervix , 1983 .

[15]  J H Hendry,et al.  Intrinsic radiosensitivity as a predictor of patient response to radiotherapy. , 1992, BJR supplement.

[16]  J. Crocker.  The nucleolar organizer regions , 1990 .

[17]  T. Grogan,et al.  Independent prognostic significance of a nuclear proliferation antigen in diffuse large cell lymphomas as determined by the monoclonal antibody Ki-67. , 1988, Blood.

[18]  Anita B. Roberts,et al.  Autocrine growth factors and cancer , 1985, Nature.

[19]  R. Orecchia,et al.  Can Ki 67 immunostaining predict response to radiotherapy in oral squamous cell carcinoma ? , 2022 .